Pictet Asset Management (UK)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$344K Sell
7,615
-478
-6% -$21.2K ﹤0.01% 1354
2021
Q1
$390K Sell
8,093
-700
-8% -$36.4K ﹤0.01% 1302
2020
Q4
$473K Hold
8,793
﹤0.01% 1185
2020
Q3
$324K Buy
+8,793
New +$327K ﹤0.01% 1201

Other funds holding NEO

Pictet Asset Management (UK)'s NEO Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its NeoGenomics (NEO) stake by 5.9% in Q2 2021, selling an estimated $21.2K and leaving 7,615 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Pictet Asset Management (UK) first reported a position in NEO in Q3 2020 and has held it in 4 quarters since. The position peaked at $473K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

  • Pictet Asset Management (UK) held 7,615 shares of NeoGenomics worth $344K as of Q2 2021.
  • Pictet Asset Management (UK) sold 478 NeoGenomics shares in Q2 2021, an estimated $21.2K.
  • NeoGenomics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1354 holding.
  • Pictet Asset Management (UK) first reported a position in NeoGenomics in Q3 2020 and has held it in 4 quarters since.
  • Pictet Asset Management (UK)'s NeoGenomics position peaked at $473K in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.